5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.65▼ | 7.79▼ | 7.83▼ | 7.92▼ | 6.73▲ |
MA10 | 7.78▼ | 7.90▼ | 7.92▼ | 7.88▼ | 5.95▲ |
MA20 | 7.90▼ | 7.94▼ | 7.98▼ | 7.03▲ | 7.04▲ |
MA50 | 8.00▼ | 8.00▼ | 7.99▼ | 5.93▲ | 5.77▲ |
MA100 | 8.00▼ | 7.97▼ | 7.22▲ | 6.99▲ | 6.47▲ |
MA200 | 8.02▼ | 6.79▲ | 6.20▲ | 5.96▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.039▼ | -0.037▼ | -0.043▼ | 0.030▲ | 0.077▲ |
RSI | 25.367▼ | 29.420▼ | 35.401▼ | 58.437▲ | 57.692▲ |
STOCH | 1.544▼ | 5.621▼ | 27.451 | 48.581 | 48.036 |
WILL %R | -97.479▼ | -97.479▼ | -97.479▼ | -43.750 | -31.818 |
CCI | -107.029▼ | -216.567▼ | -253.965▼ | 5.838 | 80.006 |
Wednesday, June 04, 2025 05:00 AM
Funding expected to support operations into Q1 2026. Anticipated AMPLIFY-7P Phase 2 interim analysis expected in Q3 2025. BOSTON, June 04, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ...
|
Thursday, May 01, 2025 06:55 AM
Shares of Elicio Therapeutics (ELTX) have been struggling lately and have lost 5.8% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean ...
|
Wednesday, April 16, 2025 01:06 PM
BOSTON, April 16, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 8.04 | 8.12 | 7.56 | 7.60 | 34,329 |
12/06/25 | 8.01 | 8.25 | 7.79 | 8.02 | 25,355 |
11/06/25 | 8.10 | 8.39 | 7.795 | 7.935 | 53,982 |
10/06/25 | 8.15 | 8.15 | 7.88 | 8.06 | 31,928 |
09/06/25 | 8.26 | 8.26 | 7.75 | 7.97 | 60,989 |
06/06/25 | 7.65 | 8.06 | 7.63 | 7.83 | 28,853 |
05/06/25 | 8.22 | 8.3897 | 7.42 | 7.47 | 40,382 |
04/06/25 | 8.03 | 8.80 | 7.85 | 8.10 | 120,038 |
03/06/25 | 8.00 | 9.00 | 8.00 | 8.08 | 65,582 |
02/06/25 | 7.19 | 8.00 | 6.90 | 7.75 | 72,416 |
|
|
||||
|
|
||||
|
|